Evidence map›Paper›PMID 36450724›Full record

ArticleNature communications2022

Author Correction: GZMK

Silvia Tiberti, Carlotta Catozzi, Ottavio Croci, Mattia Ballerini, Danilo Cagnina, Chiara Soriani, Caterina Scirgolea, Zheng Gong, Jiatai He, Angeli D Macandog and 18 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Silvia TibertiDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.
Carlotta CatozziDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0002-1028-1489
Ottavio CrociCenter for Genomic Science of IIT, CGS@SEMM (Istituto Italiano di Tecnologia at European School of Molecular Medicine), Fondazione Istituto Italiano di Tecnologia (IIT), Milano, Italy.
Mattia BalleriniDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.
Danilo CagninaDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0001-5701-935X
Chiara SorianiDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0003-4363-6597
Caterina ScirgoleaLaboratory of Translational Immunology, IRCCS- Humanitas Research Hospital-, Milan, Italy.ORCID http://orcid.org/0000-0001-9213-5532
Zheng GongThe Jackson Laboratory, Bar Harbor, ME, USA.
Jiatai HeThe Jackson Laboratory, Bar Harbor, ME, USA.
Angeli D MacandogDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.
Amir NabinejadDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0003-3276-1368
Carina B Nava LausonDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.
Arianna Quinte'Department of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.
Giovanni BertalotDepartment of Pathology, APSS Trento Hospital & Health Care, Trento, Italy.
Wanda L PetzDigestive Surgery Division, European Institute of Oncology-IRCCS, Milan, Italy.
Simona P RavendaDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology-IRCCS, Milan, Italy.
Valerio LicursiInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR) of Italy, Rome, Italy.ORCID http://orcid.org/0000-0002-8172-1437
Paola PaciDepartment of Computer, Control and Management Engineering, Sapienza - University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0002-9393-2047
Marco RasponiDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.ORCID http://orcid.org/0000-0002-2904-8652
Luca RottaDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0001-6915-1120
Nicola FazioDigestive Surgery Division, European Institute of Oncology-IRCCS, Milan, Italy.
Guangwen RenThe Jackson Laboratory, Bar Harbor, ME, USA.ORCID http://orcid.org/0000-0003-2436-9593
Uberto Fumagalli-RomarioDigestive Surgery Division, European Institute of Oncology-IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0002-6865-8971
Martin H SchaeferDepartment of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0001-7503-6364
Stefano CampanerCenter for Genomic Science of IIT, CGS@SEMM (Istituto Italiano di Tecnologia at European School of Molecular Medicine), Fondazione Istituto Italiano di Tecnologia (IIT), Milano, Italy.
Enrico LugliLaboratory of Translational Immunology, IRCCS- Humanitas Research Hospital-, Milan, Italy.ORCID http://orcid.org/0000-0002-1964-7678
Luigi Nezi *Department of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy. luigi.nezi@ieo.it.ORCID http://orcid.org/0000-0002-4670-7656
Teresa Manzo *Department of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy. teresa.manzo@ieo.it.ORCID http://orcid.org/0000-0001-8552-3625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36450724
PMCPMC9712654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.